Skip to content

Induction of Labor in Oligohydramnios

Induction of Labor in Oligohydramnios - A Comparison Between Two Modes of Cervical Ripening for Patients With Oligohydramnios at Term

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00815542
Enrollment
100
Registered
2008-12-30
Start date
2012-06-30
Completion date
2012-06-30
Last updated
2012-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Ripening

Brief summary

When oligohydramnion - decreased amniotic fluid, is diagnosed at term pregnancies, the common practice is to induce labor. Whenever the cervix is not ripened, there are several methods to ripen the cervix, two of which are: mechanical, using a double balloon catheter and pharmacological, with prostaglandins. The aim of the study is to compare those two methods of cervical ripening for patients with significant oligohydramnion at term. The study will be a prospective randomised trial.

Interventions

cervical ripening using double balloon catheter

prostaglandins E2 - Intravaginal Propess for 24 hours

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* singleton pregnancy * normal pregnancy, well dated, at term * un ripened cervix

Exclusion criteria

* previous cesarean section * multiple pregnancy * intra uterine growth restricted fetus

Design outcomes

Primary

MeasureTime frame
Time from ripening to active labor and to delivery, rates of cesarean section, rates of nonreassuring fetal heart rate during induction of labor.during induction of labor, delivery and early post partum

Secondary

MeasureTime frame
patients satisfactioninduction of labor, delivery and early postpartum

Countries

Israel

Contacts

Primary ContactTal Biron - Shental, MD
Biront@clalit.org.il972-577-482716

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026